Liraglutide for weight management in children and adolescents with Prader–Willi syndrome and obesity

G Diene, M Angulo, PM Hale, CH Jepsen… - The Journal of …, 2023 - academic.oup.com
Abstract Context Prader–Willi syndrome (PWS) is characterized by lack of appetite control
and hyperphagia, leading to obesity. Pharmacological options for weight management are …

Intranasal carbetocin reduces hyperphagia, anxiousness, and distress in prader-willi syndrome: CARE-PWS phase 3 trial

E Roof, CL Deal, SE McCandless… - The Journal of …, 2023 - academic.oup.com
Abstract Context Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by
endocrine and neuropsychiatric problems including hyperphagia, anxiousness, and …

[HTML][HTML] Neuromodulation for the treatment of Prader-Willi syndrome–A systematic review

L Qiu, A Chang, R Ma, TV Strong, MS Okun, KD Foote… - …, 2024 - Elsevier
Prader-Willi syndrome (PWS) is a complex, genetic disorder characterized by multisystem
involvement, including hyperphagia, maladaptive behaviors and endocrinological …

Caregiver burden and its relationship to health-related quality of life in craniopharyngioma survivors

N Kayadjanian, EA Hsu, AM Wood… - The Journal of Clinical …, 2024 - academic.oup.com
Context Craniopharyngioma (CP) is a rare brain tumor associated with severe comorbidities
that reduce survivor health-related quality of life (HRQOL). However, CP impact on …

Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the Magel2-null mouse model of Prader-Willi syndrome

NJ Queen, X Zou, JM Anderson, W Huang… - … Therapy-Methods & …, 2022 - cell.com
Individuals with Prader-Willi syndrome (PWS) display developmental delays, cognitive
impairment, excessive hunger, obesity, and various behavioral abnormalities. Current PWS …

Analysis of Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome

L Matesevac, CJ Vrana-Diaz, JE Bohonowych… - Scientific Reports, 2023 - nature.com
Abstract The Hyperphagia Questionnaire for Clinical Trials (HQ-CT) is an observer-reported
outcome measure that has been widely used in interventional studies to assess changes in …

Relationships between food-related behaviors, obesity, and medication use in individuals with Smith-Magenis syndrome

AA Gandhi, TA Wilson, S Sisley, SH Elsea… - Research in …, 2022 - Elsevier
Abstract Background Smith-Magenis syndrome (SMS) is a complex neurodevelopmental
disorder that includes obesity and food-seeking/satiety-related behaviors. Aims This study …

The continued impact of the COVID-19 pandemic on pediatric obesity: A commentary on the return to a healthy new “normal”

E Chaves, SD Reddy, A Cadieux, J Tomasula… - International journal of …, 2022 - mdpi.com
Two years into this pandemic, mental health symptoms are more prevalent in children and
adolescents, routine wellness visits have decreased, individuals and families are …

Caregiver burden in Bardet-Biedl syndrome: findings from the CARE-BBS study

E Forsythe, UG Mallya, M Yang, C Huber… - Orphanet Journal of …, 2023 - Springer
Abstract Background Bardet-Biedl syndrome (BBS) is a rare, genetically heterogeneous
obesity syndrome associated with hyperphagia. Given the early onset of BBS symptoms in …

[HTML][HTML] The effect of family-centered education on the Care Burden of Family caregivers of the Elderly with Cancer: a quasi-experimental study

A Wasmani, M Rahnama… - Asian Pacific journal …, 2022 - ncbi.nlm.nih.gov
Methods: In this quasi-experimental study, 30 elderly caregivers with cancer were selected
and randomly divided into two groups of 15 intervention and 15 control from 1 March 2020 to …